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XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via 
a post-translational modification mechanism
B Zou1,2, JCS Chim2, R Pang1,2, CSC Lam1,2, IFN Hung1,2, VPY Tan1,2, HY Lan3, BCY Wong1,2
1Department of Medicine, The University of Hong Kong, Hong Kong
2Center for Cancer Research, The University of Hong Kong, Hong Kong
3Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Background: X chromosome–linked inhibitor of apoptosis protein (XIAP)–associated factor 1 (XAF1) acts as a 
negative regulator of the IAP family members to mediate apoptosis. The present study aimed to determine the 
putative interaction and mechanism between XAF1 and p53 in human gastric and colon cancer cells, especially 
during process of apoptosis.
Methods: Using chromatin immunoprecipitation (CHIP) assay to investigate the interaction between p53 protein 
and XAF1 promoter. The XAF1 and p53 expressions were detected by reverse transcription–polymerase chain 
reaction (PCR) and western blot analysis. Luciferase reporter assays were used to detect activities of various 
promoter of XAF1 and p53 transcriptional regulation. UV exposure and adriamycin (ADR) were used to induce 
DNA damage on stable cell line AGS with high expression of XAF1.
Results: We first showed that XAF1 is a novel target gene of p53. Wild type but not mutant p53 was able to 
downregulate XAF1 at both mRNA and protein levels, which initiated from physical interaction with XAF1 
promoter. In turn, over-expression of XAF1 was capable of activating p53 via post-translational modification in 
response to DNA damage, thereby resulting in enhancing p53 nuclear accumulation and transcriptional activity. 
In addition, XAF1 enhanced p53-dependent apoptosis.
Conclusions: These results suggest that XAF1 is a novel target gene of p53. Moreover, XAF1 can activate p53-
mediated apoptosis via enhancing the post-translational modification of p53.
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Background: Loss of function of Krev interaction trapped-1 (Krit1) mutations contributed to cerebral cavernous 
malformation-1 (CCM1). Krit1 may help determine cell shape and adhesion, both crucial in angiogenesis. The 
aim of this study was to elucidate the potential mechanism of Krit1-midiated cell proliferation and metastasis in 
colon cancers.
Methods: Human colon cancer cell line HCT116 was stably transfected with full-length Krit1. Cell proliferation 
and invasion were measured by colony formation assay, invasion assay, and wound healing assay. Both xenograph 
nude mice tumour model and orthotopic nude mice tumour model were used to investigate the effects of Krit1 
overexpression on tumour growth and metastasis.
Results: Overexpression of Krit1 in HCT116 cells resulted in down-regulation of colony formation (P<0.01) and 
inhibition of wound recovery and invasion. Stable expression of Krit1 significantly decreased tumour volume 
(P<0.05) and the incidence of liver metastasis in vivo. Our studies showed that overexpression of Krit1 led to 
restoration of dipeptidyl peptides IV (DPPIV) expression, which in association with decreased expression of 
downstream chemokine stromal–derived factor1 (SDF1) and its receptor CXCR4. DPPIV inhibitor Diprotin A 
treatment resulted in restoration of cell proliferation and migration potential in Krit1 stable expressed cells.
Conclusions: Our results showed that in colon cancer Krit1 inhibited cell proliferation and invasiveness by 
upregulation of DPPIV signalling pathway.
